USPTO serial 79215315
LIMMATECH BIOLOGICS BETTER TECHNOLOGY FOR BETTER HEALTH
Reviewed by CopyMark Law Group
Reg. 5619534Status 709
- Filing date
- Status date
- Registration date
- Dec 4, 2018
- Examiner
- CROWDER-SCHAEFER, ANDREW W
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with LIMMATECH BIOLOGICS BETTER TECHNOLOGY FOR BETTER HEALTH?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Christina L. Martini, Esq.
Christina L. Martini, Esq. DLA Piper LLP (US)P. O. Box 64807Chicago, IL 60664-0807UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical products for the treatment of any disease or conditions to be treated by means of therapeutics and vaccines, namely, cancer, autoimmune, inflammatory, bacterial and viral diseases; all the aforesaid goods of Swiss origin | SECTION 71 - CANCELLED | — |
| 016 | Packaging, namely, blister packs; packages, namely, boxes of cardboard and paper; promotional material in the nature of advertising posters, instructional sheets in the field of pharmaceuticals, and information material in the nature of pharmaceutical information leaflets; paper, cardboard, printed teaching materials in the field of pharmaceuticals; printed products, namely, leaflets for pharmaceutical products, pamphlets in the field of pharmaceuticals, manuals in the field of pharmaceuticals, leaflets about pharmaceutical preparations for the treatment of disorders to be treated by means of therapeutics and vaccines, posters, prospectuses featuring information concerning company business in the nature of pharmaceutical products, newsletters about company business in the nature of pharmaceutical products, document files; photographs; graphic representations; business cards; all the aforesaid goods are of Swiss origin | SECTION 71 - CANCELLED | — |
| 041 | Training courses related to research and development of pharmaceuticals; organizing conferences in the field of education for non-business and/or non-commercial purposes; arranging and conducting educational conferences in the field of pharmaceuticals; arranging of seminars; organizing educational conferences in the field of teaching; organization of in-person educational, forum in the field of pharmaceuticals; organization of educational seminars, and organizing conferences in the field of education; organizing conferences in the field of pharmaceuticals and conducting of educational conferences for non-business and/or non-commercial purposes; organizing educational conferences and symposiums in the field of medical science; editing of written text in the nature of medical publications; publication of printed materials and printed publications, namely, magazines; newspapers, leaflets; publication of texts; all the aforesaid services from Switzerland | SECTION 71 - CANCELLED | — |
| 042 | Scientific research services; medical research; biological research services; clinical research in the field of pharmaceuticals; scientific research and providing information in the fields of biochemistry and biotechnology; genetic research; biological research, clinical research in the field of therapeutics and vaccines, and medical research; product research; laboratory research in the field of pharmaceuticals; technical research in the field of pharmaceutical studies; scientific research; scientific research and development; providing laboratory research services in the field of therapeutics and vaccines; scientific research in the field of biology; information relating to scientific research, namely, scientific research information in the field of pharmaceutical; research in the field of molecular science; scientific research in the field of genetics; product research and development in the field of biotechnology; laboratory research services in the field of dermatology; scientific research in the field of genetics and genetic engineering; providing medical and scientific research information in the field of pharmaceutical products and clinical trials; all the aforesaid services from Switzerland | SECTION 71 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by LIMMATECH BIOLOGICS AG
- Other trademarks owned by LIMMATECH BIOLOGICS AG
- Other trademarks owned by LIMMATECH BIOLOGICS AG
- Other trademarks in Class 005
- Other trademarks in Class 016
- Other trademarks in Class 041
- Other trademarks in Class 042
- Similar marks named LIMMATECH BIOLOGICS BETTER TECHNOLOGY FOR BETTER HEALTH
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 28, 2026 | INTS | TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB | — |
| Oct 28, 2026 | INPC | INVALIDATION PROCESSED | — |
| Feb 20, 2026 | INTR | TOTAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Jun 20, 2025 | C71T | CANCELLED SECTION 71 | — |
| Dec 4, 2023 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| May 10, 2019 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Mar 19, 2019 | XXSS | GENERIC MADRID TRANSACTION SENT TO IB | — |
| Mar 19, 2019 | XXCR | GENERIC MADRID TRANSACTION CREATED | — |
| Mar 4, 2019 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Jan 4, 2019 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Dec 4, 2018 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Sep 18, 2018 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Sep 18, 2018 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Sep 15, 2018 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Aug 29, 2018 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Aug 29, 2018 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Aug 29, 2018 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Aug 10, 2018 | ALIE | ASSIGNED TO LIE | — |
| Aug 1, 2018 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jul 25, 2018 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Jul 25, 2018 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Jul 25, 2018 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Jul 25, 2018 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Apr 23, 2018 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Apr 23, 2018 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Apr 23, 2018 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Mar 19, 2018 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Mar 17, 2018 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 17, 2018 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 17, 2018 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Mar 16, 2018 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 16, 2018 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Oct 7, 2017 | RFNT | REFUSAL PROCESSED BY IB | — |
| Sep 18, 2017 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Sep 18, 2017 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Sep 14, 2017 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Sep 13, 2017 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 9, 2017 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Sep 5, 2017 | DOCK | ASSIGNED TO EXAMINER | — |
| Sep 5, 2017 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Aug 31, 2017 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |